Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001710300 | SCV001938242 | benign | not provided | 2020-04-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001710300 | SCV002152310 | benign | not provided | 2024-12-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002440841 | SCV002752715 | benign | Inborn genetic diseases | 2018-12-03 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003910969 | SCV004719838 | likely benign | RAI1-related disorder | 2022-03-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |